Dae Geun Park, Yoona Chung, Sang Hyun Kim, Yong Jin Kim
{"title":"袖式胃切除术或Roux-en-Y胃旁路术后糖尿病缓解率的研究利用韩国患者的个体化代谢手术评分。","authors":"Dae Geun Park, Yoona Chung, Sang Hyun Kim, Yong Jin Kim","doi":"10.17476/jmbs.2020.9.1.13","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study is to evaluate the usefulness of individualized metabolic surgery score for Korean patients in determining bariatric surgical procedures.</p><p><strong>Materials and methods: </strong>A total of 135 patients with type 2 diabetes mellitus who underwent sleeve gastrectomy (n=19) or Roux-en-Y gastric bypass (n=116) at our institute with a 1-year follow up were analyzed for the predictive power of diabetes remission using the individualized metabolic surgery scoring system.</p><p><strong>Results: </strong>At the postoperative follow-up of 1 year, the remission of type 2 diabetes mellitus (HbA<sub>1C</sub><6.5%, off medications) was achieved in 88 (65.2%) patients. The remission rates showed no significant differences between patients who underwent sleeve gastrectomy and Roux-en-Y gastric bypass (63.2% versus 65.5%; P=0.84), regardless of the severity of type 2 diabetes mellitus. Although there was no statistically significant difference in the remission rate according to the bariatric surgery procedures (P>0.99 in mild, P=0.11 in moderate, P>0.99 in severe IMS score), remission rates were higher in moderate severity patients who underwent Roux-en-Y gastric bypass than in those who underwent sleeve gastrectomy (69.7% versus 37.5%).</p><p><strong>Conclusion: </strong>The remission rates after bariatric surgery procedures were similar to that of the previously reported study. Despite the limitations of our data, the individualized metabolic surgery score can be used as a complement to other scoring systems in Korean patients.</p>","PeriodicalId":73828,"journal":{"name":"Journal of metabolic and bariatric surgery","volume":"9 1","pages":"13-18"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/a3/jmbs-9-13.PMC9847645.pdf","citationCount":"3","resultStr":"{\"title\":\"Diabetes Remission Rate after Sleeve Gastrectomy or Roux-en-Y Gastric Bypass; Utilizing Individualized Metabolic Surgery Score for Korean Patients.\",\"authors\":\"Dae Geun Park, Yoona Chung, Sang Hyun Kim, Yong Jin Kim\",\"doi\":\"10.17476/jmbs.2020.9.1.13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The purpose of this study is to evaluate the usefulness of individualized metabolic surgery score for Korean patients in determining bariatric surgical procedures.</p><p><strong>Materials and methods: </strong>A total of 135 patients with type 2 diabetes mellitus who underwent sleeve gastrectomy (n=19) or Roux-en-Y gastric bypass (n=116) at our institute with a 1-year follow up were analyzed for the predictive power of diabetes remission using the individualized metabolic surgery scoring system.</p><p><strong>Results: </strong>At the postoperative follow-up of 1 year, the remission of type 2 diabetes mellitus (HbA<sub>1C</sub><6.5%, off medications) was achieved in 88 (65.2%) patients. The remission rates showed no significant differences between patients who underwent sleeve gastrectomy and Roux-en-Y gastric bypass (63.2% versus 65.5%; P=0.84), regardless of the severity of type 2 diabetes mellitus. Although there was no statistically significant difference in the remission rate according to the bariatric surgery procedures (P>0.99 in mild, P=0.11 in moderate, P>0.99 in severe IMS score), remission rates were higher in moderate severity patients who underwent Roux-en-Y gastric bypass than in those who underwent sleeve gastrectomy (69.7% versus 37.5%).</p><p><strong>Conclusion: </strong>The remission rates after bariatric surgery procedures were similar to that of the previously reported study. Despite the limitations of our data, the individualized metabolic surgery score can be used as a complement to other scoring systems in Korean patients.</p>\",\"PeriodicalId\":73828,\"journal\":{\"name\":\"Journal of metabolic and bariatric surgery\",\"volume\":\"9 1\",\"pages\":\"13-18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/a3/jmbs-9-13.PMC9847645.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of metabolic and bariatric surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17476/jmbs.2020.9.1.13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of metabolic and bariatric surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17476/jmbs.2020.9.1.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
目的:本研究的目的是评估个体化代谢手术评分对韩国患者决定减肥手术程序的有用性。材料与方法:本研究采用个体化代谢手术评分系统对我院135例2型糖尿病患者进行1年随访的袖式胃切除术(n=19)或Roux-en-Y胃旁路术(n=116)进行糖尿病缓解的预测能力分析。结果:术后随访1年,2型糖尿病缓解(轻度HbA1C0.99,中度P=0.11,重度IMS评分P>0.99),中度Roux-en-Y胃分流术患者缓解率高于套管胃切除术患者(69.7% vs 37.5%)。结论:减肥手术后的缓解率与先前报道的研究相似。尽管我们的数据有局限性,但在韩国患者中,个性化代谢手术评分可以作为其他评分系统的补充。
Diabetes Remission Rate after Sleeve Gastrectomy or Roux-en-Y Gastric Bypass; Utilizing Individualized Metabolic Surgery Score for Korean Patients.
Purpose: The purpose of this study is to evaluate the usefulness of individualized metabolic surgery score for Korean patients in determining bariatric surgical procedures.
Materials and methods: A total of 135 patients with type 2 diabetes mellitus who underwent sleeve gastrectomy (n=19) or Roux-en-Y gastric bypass (n=116) at our institute with a 1-year follow up were analyzed for the predictive power of diabetes remission using the individualized metabolic surgery scoring system.
Results: At the postoperative follow-up of 1 year, the remission of type 2 diabetes mellitus (HbA1C<6.5%, off medications) was achieved in 88 (65.2%) patients. The remission rates showed no significant differences between patients who underwent sleeve gastrectomy and Roux-en-Y gastric bypass (63.2% versus 65.5%; P=0.84), regardless of the severity of type 2 diabetes mellitus. Although there was no statistically significant difference in the remission rate according to the bariatric surgery procedures (P>0.99 in mild, P=0.11 in moderate, P>0.99 in severe IMS score), remission rates were higher in moderate severity patients who underwent Roux-en-Y gastric bypass than in those who underwent sleeve gastrectomy (69.7% versus 37.5%).
Conclusion: The remission rates after bariatric surgery procedures were similar to that of the previously reported study. Despite the limitations of our data, the individualized metabolic surgery score can be used as a complement to other scoring systems in Korean patients.